Hyperkalemia in heart failure patients: current challenges and future prospects

Hyperkalemia in heart failure patients: current challenges and future prospects

Raquel López-Vilella, Herminio Morillas-Climent, Diego Plaza-López, Mónica Cebrián-Pinar, Ignacio Sánchez-Lázaro, Luis Almenar-Bonet Heart Failure and Heart Transplant Unit, Cardiology Department, Hospital La Fe, Valencia, Spain Abst...

Full description

Bibliographic Details
Main Authors:	López-Vilella R, Morillas-Climent H, Plaza-López D, Cebrián-Pinar M, Sánchez-Lázaro I, Almenar-Bonet L
Format:	Article
Language:	English
Published:	Dove Medical Press 2016-02-01
Series:	Research Reports in Clinical Cardiology
Subjects:	Hyperkalemia heart failure renin angiotensin aldosterone system (RAAS) inhibitors.
Online Access:	https://www.dovepress.com/hyperkalemia-in-heart-failure-patients-current-challenges-and-future-p-peer-reviewed-article-RRCC

Similar Items

Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD
by: Anastasia V. Poznyak, et al.
Published: (2021-06-01)

Role of renin–angiotensin–aldosterone system inhibitors in heart failure and chronic kidney disease
by: Namrata Singhania, et al.
Published: (2020-11-01)

Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension
by: Natalia Muñoz-Durango, et al.
Published: (2016-06-01)

Renin-angiotensin-aldosteron system: evolution of views from renin discovery to nowadays. Perspectives of therapeutic block
by: Marina Vladimirovna Shestakova, et al.
Published: (2011-04-01)

A Model to Predict Risk of Hyperkalemia in Patients with Chronic Kidney Disease Using a Large Administrative Claims Database
by: Sharma A, et al.
Published: (2020-11-01)

Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
by: Luz Lozano-Maneiro, et al.
Published: (2015-11-01)

Dynamic Changes in the Renin-Angiotensin-Aldosterone System and the Beneficial Effects of Renin-Angiotensin-Aldosterone Inhibitors on Spatial Learning and Memory in a Rat Model of Chronic Cerebral Ischemia
by: Xinwu Huang, et al.
Published: (2017-06-01)

The Impact of Vitamin D in the Treatment of Essential Hypertension
by: Christian Legarth, et al.
Published: (2018-02-01)

Effects of Interactions among Gene Polymorphisms of the Renin–Angiotensin-Aldosterone System on Hypertension in Turkish People from Southeast Anatolia
by: Arpacı Abdullah, et al.
Published: (2019-04-01)

The Central Role of Fibrinolytic Response in COVID-19—A Hematologist’s Perspective
by: Hau C. Kwaan, et al.
Published: (2021-01-01)

Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic
by: Simon B. Gressens, et al.
Published: (2021-02-01)

Renin Activity in Heart Failure with Reduced Systolic Function—New Insights
by: Ryan D. Sullivan, et al.
Published: (2019-06-01)

Angiotensin-Converting Enzyme 2 (ACE2) as a Potential Diagnostic and Prognostic Biomarker for Chronic Inflammatory Lung Diseases
by: Dejan Marčetić, et al.
Published: (2021-07-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
by: M L Maksimov
Published: (2010-06-01)

Renin Feedback Is an Independent Predictor of Outcome in HFpEF
by: Christina Binder, et al.
Published: (2021-05-01)

Endoplasmic Reticulum (ER) Stress in Part Mediates Effects of Angiotensin II in Pancreatic Beta Cells
by: Ramalingam L, et al.
Published: (2020-08-01)

Effect of sodium–glucose cotransporter-2 inhibitors on aldosterone-to-renin ratio in diabetic patients with hypertension: a retrospective observational study
by: Toshitaka Sawamura, et al.
Published: (2020-11-01)

How to potentialize the effect of renin-angiotensin-aldosterone system inhibitors?
by: D.D. Ivanov
Published: (2021-09-01)

Mechanical strategies to improve fluid over load in patients with cardiorenal syndrome
by: Murthy
Published: (2013-03-01)

Investigations of Renin-Angiotensin Aldosterone System (RAAS) genes in hypertrophy in hypertrophic cardiomyopathy (HCM) founder families
by: Cloete, Ruben Earl Ashley
Published: (2012)

Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST)
by: Melissa Coffman, et al.
Published: (2021-07-01)

Prospects of using genetic testing to increase the effectiveness of antihypertensive therapy
by: N. V. Drobotya, et al.
Published: (2020-06-01)

Pharmacodynamic effects of the K+ binder patiromer in a novel chronic hyperkalemia model in spontaneously hypertensive rats
by: Sai Prasad N. Iyer, et al.
Published: (2020-09-01)

Persistent severe hyperkalemia following surgical treatment of aldosterone-producing adenoma
by: Cristina Preda, et al.
Published: (2020-01-01)

The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
by: Piotr Jędrusik, et al.
Published: (2021-05-01)

Hyporeninemic hypoaldosteronism in a patient with diabetes mellitus: an unforgettable case report
by: Chelaghma N, et al.
Published: (2018-04-01)

The effect of calcifediol supplementation on renin-angiotensin-aldosterone system mediators in dogs with chronic kidney disease
by: Miller, Matthew Scott
Published: (2021)

Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
by: Yudi Her Oktaviono, et al.
Published: (2020-04-01)

Aliskiren: An orally active renin inhibitor
by: Pranay Wal, et al.
Published: (2011-01-01)

The renin–angiotensin–aldosterone-system and right heart failure in congenital heart disease
by: Stine Andersen, et al.
Published: (2016-06-01)

Beyond the circulating renin angiotensin aldosterone system
by: Walmor eDe Mello
Published: (2014-07-01)

What is the optimal choice of antihypertensive therapy based on: the class-specific effects or special properties of a drug?
by: T V Adasheva, et al.
Published: (2013-09-01)

RAAS: A Convergent Player in Ischemic Heart Failure and Cancer
by: Texali C. Garcia-Garduño, et al.
Published: (2021-07-01)

Antihypertensive Effects of <i>Gynura divaricata</i> (L.) DC in Rats with Renovascular Hypertension
by: Mi Hyeon Hong, et al.
Published: (2020-10-01)

Mechanisms and Modulation of Oxidative/Nitrative Stress in Type 4 Cardio-Renal Syndrome and Renal Sarcopenia
by: Márta Sárközy, et al.
Published: (2018-11-01)

Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy
by: Kalathil K Sureshkumar
Published: (2008-12-01)

Effect of Ramipril on Renin-Angiotensin-Aldosterone System of Young and Middle-Aged Patients with Hypertension
by: Hui-Ling Yuan
Published: (2020-12-01)

Successful management of an infant with hypertensive heart failure associated with Wilms’ tumor: a case report
by: Hiroko Miura, et al.
Published: (2020-02-01)

Evaluation of Systemic Renin and Angiotensin II Levels in Normal Tension Glaucoma
by: Soo Ji Jeon, et al.
Published: (2020-11-01)

Prevalence of an angiotensin-converting enzyme gene variant in dogs
by: D. B. Adin, et al.
Published: (2021-07-01)